Division of Redox Biology and Pathology

Our mission is to increase our understanding of redox-based mechanisms in the pathology of chronic disease, and to develop novel diagnostic tools to assess redox mechanisms in (patho)biology and new targeted redox-based therapeutic strategies.

RBP Faculty

NameTitleContact Information
Vikas Anath, Ph.D.Professor / Division ChiefVikas.Anathy@med.uvm.edu | (802) 656-0395
Reem Aboushousha, Ph.D.
Faculty Scientist
Reem.Aboushousha@med.uvm.edu | (802) 656-4573
Brian S. Cunniff, Ph.D.Assistant ProfessorBrian.Cunniff@uvm.edu | (802) 656-9899
Yvonne Janssen-Heininger, Ph.D.ProfessorYvonne.Janssen@uvm.edu | (802) 656-0995
Amit Kumar, Ph.D.Faculty Scientist
Amit.Kumar@med.uvm.edu | (802) 656-8743
Arti Shukla, Ph.D.ProfessorArti.Shukla@uvm.edu | (802) 656-8253
Douglas J. Taatjes, Ph.D.Professor / Director of the Microscopy Imaging Center / Director of the Center for Biomedical Shared ResourcesDouglas.Taatjes@uvm.edu | (802) 656-0373
Albert van der Vliet, Ph.D.ProfessorAlbert.van-der-Vliet@uvm.edu | (802) 656-8638
Vernon E. Walker, DVM, Ph.D.Associate Professor
Vernon.Walker@med.uvm.edu | (802) 656-3126

Teamwork

Training

Body

Our Redox Biology and Pathology labs provide active training environments for undergraduate, graduate, and postdoctoral researchers. Faculty are dedicated mentors and contribute to biomedical education across multiple programs within the College and broader university.

Support

Body

Research in the Redox Biology and Pathology program is supported by a combination of federal grants, foundation funding, and industry partnerships. Current and past sponsors include the National Institutes of Health (NIH), Department of Defense, American Lung Association (ALA), Mesothelioma Applied Research Foundation, and American Asthma Foundation. Several investigators also engage in biotech collaborations focused on intellectual property, patent development, and commercial translation.

Collaboration

Body

Redox Biology and Pathology researchers work closely with UVM Innovations and external sponsors to advance scientific discoveries with clinical and commercial potential.